ATE519760T1 - Isoxazolimidazolderivate - Google Patents

Isoxazolimidazolderivate

Info

Publication number
ATE519760T1
ATE519760T1 AT08760925T AT08760925T ATE519760T1 AT E519760 T1 ATE519760 T1 AT E519760T1 AT 08760925 T AT08760925 T AT 08760925T AT 08760925 T AT08760925 T AT 08760925T AT E519760 T1 ATE519760 T1 AT E519760T1
Authority
AT
Austria
Prior art keywords
isoxazolimidazole
derivatives
isoxazolimidazole derivatives
Prior art date
Application number
AT08760925T
Other languages
English (en)
Inventor
Bernd Buettelmann
Roland Jakob-Roetne
Henner Knust
Andrew Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39735035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE519760(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE519760T1 publication Critical patent/ATE519760T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT08760925T 2007-06-22 2008-06-12 Isoxazolimidazolderivate ATE519760T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07110846 2007-06-22
PCT/EP2008/057384 WO2009000662A1 (en) 2007-06-22 2008-06-12 Isoxazole-imidazole derivatives

Publications (1)

Publication Number Publication Date
ATE519760T1 true ATE519760T1 (de) 2011-08-15

Family

ID=39735035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08760925T ATE519760T1 (de) 2007-06-22 2008-06-12 Isoxazolimidazolderivate

Country Status (17)

Country Link
US (1) US7851469B2 (de)
EP (1) EP2170873B1 (de)
JP (1) JP5416103B2 (de)
KR (1) KR101228194B1 (de)
CN (1) CN101965344B (de)
AR (1) AR067075A1 (de)
AT (1) ATE519760T1 (de)
AU (1) AU2008267894B2 (de)
BR (1) BRPI0814718A2 (de)
CA (1) CA2690975A1 (de)
CL (1) CL2008001820A1 (de)
ES (1) ES2369805T3 (de)
IL (1) IL202667A0 (de)
MX (1) MX2009014001A (de)
PE (1) PE20090839A1 (de)
TW (1) TW200911795A (de)
WO (1) WO2009000662A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103003265A (zh) 2010-07-19 2013-03-27 先正达参股股份有限公司 杀微生物剂
CN103003268A (zh) 2010-07-19 2013-03-27 先正达参股股份有限公司 作为杀微生物剂的异噁唑、异噻唑、呋喃以及噻吩化合物
US8466181B2 (en) * 2010-12-10 2013-06-18 Hoffmann-La Roche Inc. 1,2,3-triazole-imidazole compounds
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP2885290B1 (de) 2012-06-26 2017-10-18 Saniona A/S Ein phenyl triazol derivat und seine verwendung zur modulation des gabaa receptor komplexes
WO2014001279A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
WO2014001278A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
MX357504B (es) 2012-06-26 2018-07-12 Saniona Aps Derivado de feniltriazol y su uso para modular complejo del receptor gabaa.
WO2014001280A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
CN110621669A (zh) 2017-05-04 2019-12-27 巴斯夫欧洲公司 防除植物病原性真菌的取代5-卤代烷基-5-羟基异噁唑类
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525205A1 (de) * 1984-09-11 1986-03-20 Hoechst Ag, 6230 Frankfurt Pflanzenschuetzende mittel auf basis von 1,2,4-triazolderivaten sowie neue derivate des 1,2,4-triazols
GB9808663D0 (en) 1998-04-23 1998-06-24 Merck Sharp & Dohme Therapeutic agents
US6660753B2 (en) * 1999-08-19 2003-12-09 Nps Pharmaceuticals, Inc. Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
IT1314191B1 (it) 1999-10-18 2002-12-06 Recordati Chem Pharm Derivati isossazolcarbossamidici
AU1481701A (en) 1999-11-12 2001-06-06 Neurogen Corporation Bicyclic and tricyclic heteroaromatic compounds
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
GB0108475D0 (en) 2001-04-04 2001-05-23 Merck Sharp & Dohme New compounds
MXPA03011886A (es) 2001-07-05 2005-03-07 Lundbeck & Co As H Piperidinias anilinicas sustituidas como antagonistas selectivos de mch.
DE60225174T2 (de) 2001-11-20 2009-02-12 Eli Lilly And Co., Indianapolis Beta-3 adrenergische agonisten
GB0128160D0 (en) 2001-11-23 2002-01-16 Merck Sharp & Dohme Novel compounds
US20040132755A1 (en) * 2002-09-06 2004-07-08 Mark Ledeboer Isoxazoles and uses thereof
EP4101846B1 (de) * 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazolbenzoesäureverbindungen und deren verwendung zur nonsense-unterdrückung und behandlung von krankheiten
GB0318447D0 (en) 2003-08-05 2003-09-10 Merck Sharp & Dohme Therapeutic agents
EP1756086B1 (de) 2004-06-01 2008-06-04 F.Hoffmann-La Roche Ag Pyridin-4-yl-ethynylimidazole und -pyrazole als antagonisten des mglu5-rezeptors
WO2005123672A2 (en) 2004-06-14 2005-12-29 Takeda San Diego, Inc. Kinase inhibitors
EP1812427A4 (de) 2004-10-15 2009-10-14 Scripps Research Inst Oxadiazolketone als inhibitoren von fettsäureamidhydrolase
US20070060589A1 (en) 2004-12-21 2007-03-15 Purandare Ashok V Inhibitors of protein arginine methyl transferases
ATE538118T1 (de) * 2004-12-28 2012-01-15 Aska Pharm Co Ltd Pyrimidinylisoxazolderivat
PL1968973T3 (pl) * 2005-12-27 2012-03-30 Hoffmann La Roche Pochodne aryloizoksazol-4-iloimidazolu
ATE537171T1 (de) * 2005-12-27 2011-12-15 Hoffmann La Roche Aryl-isoxazol-4-yl-imidazoä1,5-aüpyridin-deriva e
KR101062583B1 (ko) * 2006-01-17 2011-09-06 에프. 호프만-라 로슈 아게 Ｇａｂａ 수용체에 의해 알츠하이머병의 치료에 유용한아릴-아이속사졸-4-일-이미다조[1,2-ａ]피리딘

Also Published As

Publication number Publication date
US7851469B2 (en) 2010-12-14
IL202667A0 (en) 2010-06-30
WO2009000662A1 (en) 2008-12-31
AR067075A1 (es) 2009-09-30
MX2009014001A (es) 2010-01-28
JP2010530862A (ja) 2010-09-16
CA2690975A1 (en) 2008-12-31
PE20090839A1 (es) 2009-07-02
EP2170873A1 (de) 2010-04-07
CN101965344B (zh) 2013-03-06
CN101965344A (zh) 2011-02-02
KR101228194B1 (ko) 2013-01-30
US20090005370A1 (en) 2009-01-01
AU2008267894A1 (en) 2008-12-31
CL2008001820A1 (es) 2009-05-29
ES2369805T3 (es) 2011-12-07
EP2170873B1 (de) 2011-08-10
AU2008267894B2 (en) 2012-08-23
BRPI0814718A2 (pt) 2015-02-24
KR20100023042A (ko) 2010-03-03
JP5416103B2 (ja) 2014-02-12
TW200911795A (en) 2009-03-16

Similar Documents

Publication Publication Date Title
CY2024031I1 (el) Παραγωγο 4-πυριμιδινοσουλφαμιδης
DK2164844T3 (da) Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da) Pyrimidinsubstituerede purinderivater
BRPI0813836A2 (pt) Derivados pirazólicos
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0817935A2 (pt) Derivados de biarila
ATE518837T1 (de) Indazolamidderivate
DK2308877T3 (da) Imidazopyridin-2-on-derivater
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
EP2226315A4 (de) 2-aminochinazolin-derivat
DK2152370T3 (da) Aryletherpyridazinonderivater
BRPI0814236A2 (pt) Derivados de quinazolinamida
DK2035394T3 (da) 2-pyrazincarboxamidderivater
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
DK2275414T3 (da) Cyclopentylacrylamidderivat
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
ATE545635T1 (de) Substituierte n-oxidpyrazinderivate
BRPI0812994A2 (pt) Microbiocidas
BRPI0814718A2 (pt) Derivados de isoxazol-imidazol

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2170873

Country of ref document: EP